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Abstract
Introduction: High endemic levels of pulmonary tuberculosis in prisons result from overcrowding, limited access to healthcare, 
delayed diagnosis, sustained transmission owing to poor control measures, and multidrug resistance. This study evaluated locally 
implemented measures for early pulmonary tuberculosis diagnosis and evaluated resistance to anti-tuberculosis drugs. Methods: 
This transversal study employed data from the Mato Grosso do Sul State Tuberculosis Control Program obtained from 35 correctional 
facilities in 16 counties for 2 periods (2007-2010 and 2011-2014). Results: Statewide prevalence (per 100,000) was 480.0 in 2007 
and 972.9 in 2014. The following indicators showed improvement: alcohol–acid-fast bacillus testing (from 82.7% to 92.9%); cultures 
performed (55.0% to 81.8%); drug susceptibility testing of positive cultures (71.6% to 62.4%); and overall drug susceptibility 
testing coverage (36.6% to 47.4%). Primary and acquired resistance rates for 2007-2014 were 21.1% and 30.0%, respectively. 
Primary and acquired multidrug resistance rates were 0.3% and 1.3%, respectively. Conclusions: Prevalence rates increased, and 
laboratory indicators improved as a result of capacity building and coordination of technical teams and other individuals providing 
healthcare to inmates. Resistance rates were high, thereby negatively affecting disease control.
Keywords: Mycobacterium tuberculosis. Laboratory diagnosis. Prisons. Transnational borders. South America.
INTRODUCTION
Despite recent advances in control measures, tuberculosis 
is the principal infectious disease among inmates in Brazil1, 
surpassing by up to 81 times the national average prevalence 
rate in the general population2,3, indicating that controlling the 
disease remains a neglected priority4.
In the midwestern State of Mato Grosso do Sul, the risk of 
pulmonary tuberculosis (PTB) is 25.3 times higher in prison 
population than in the general population5. In the prison 
population, a number of vulnerabilities–overcrowding, late 
detection of the disease, poorly ventilated facilities, malnutrition, 
inadequate control of cases and contacts, high HIV prevalence, 
alcohol, and illicit drugs–are likely to interact, facilitating 
infection with Mycobacterium tuberculosis and progression of 
disease2,6-9. In addition, a high turnover rate within and across 
prisons10, poor access to healthcare, and low adherence to 
treatment contribute to delayed diagnosis2,7, maintenance of the 
transmission chain, and emergence of multiresistant strains10. 
Efforts to provide healthcare to inmates is often hampered 
by logistical challenges, underfunding, lack of political 
commitment, and governmental negligence11. However, 
improving the physical structure of prisons (with gains in natural 
ventilation) and reducing cell crowding should mitigate the 
burden of disease in this population9,12 and indirectly, mitigate 
the burden of a disease in the society as a whole3,4,13.
Along with the urgency of improving the early diagnosis 
capacity in Mato Grosso do Sul prisons, strategies to detect cases 
and reduce transmission among present inmates and recently 
released inmates have been reported13. 
In a mass screening of 12 prisons in the state, 691 inmates 
who presented with cough were evaluated using sputum 
smear microscopy and sputum cultures. Sputum smear 
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microscopy failed to confirm 74% of tuberculosis cases, which 
were subsequently confirmed by culturing two samples14, 
demonstrating the effectiveness of this approach in early 
diagnosis.
In 2010, smear testing along with cultures was implemented 
for suspected tuberculosis cases among inmates serving 
sentences in the state. Comparing laboratory results obtained 
before and after the implementation of these measures and 
expanding the investigation of resistance to antituberculosis 
drugs in this population can reveal the impact of these changes.
METHODS
Study type
This transversal study employed secondary data of the prison 
population of Mato Grosso do Sul.
Overview 
Of the 2,382,083 residents estimated in the 78 counties 
in Mato Grosso do Sul in 2007, 9,322 (0.4%) were serving 
sentences in 35 correctional facilities subordinated to the Mato 
Grosso do Sul State Penal System Administration Agency 
(AGEPEN-MS) in 16 counties. By 2014, those numbers had 
risen to 2,619.657 residents and 14,904 inmates (0.5%). From 
January 2007 to December 2014, 8,032 PTB cases were reported 
to the state’s branch of the Brazilian Information System of 
Notifiable Hazards (SINAN-SES-MS), with 1,012 cases being 
inmates held in AGEPEN-MS–managed prisons. Duplicate 
notifications for the same episode or for inmates transferred 
from other states or held at police precincts were excluded.
Ethical considerations 
The study was approved by the Research Ethics Committee 
of the Universidade Federal de Mato Grosso do Sul (opinion 
252,447). 
Variables investigated
Alcohol-acid-fast bacillus (AAFB) testing, M. tuberculosis 
culture, and drug susceptibility testing (DST) results were 
retrieved from the Central Public Health Laboratory of Mato 
Grosso do Sul (LACEN-MS) or the Mato Grosso do Sul 
Laboratory Environment Management Database (LAG-MS) 
and double-checked. Cases were grouped by year for the entire 
state and for the following three groups: cases originating from 
the Jair Ferreira de Carvalho Correctional Facility (JFCCF), in 
Campo Grande, the state capital (Group 1); cases from other 
correctional facilities in Campo Grande (Group 2); and cases 
from prisons in other counties in Mato Grosso do Sul (Group 3). 
We distributed cases into these three groups because 2006 
samples for AAFB testing that were collected outside of Campo 
Grande were locally processed at municipal laboratories and 
subsequently sent to the LACEN-MS in Campo Grande for 
culturing and DST. Samples from the JFCCF were processed for 
AAFB testing in the Campo Grande municipal laboratory and 
subsequently cultured at the LACEN-MS. However, since 2010, 
the LACEN-MS has been responsible for processing AAFB 
testing for all samples originating from the JFCCF. Furthermore, 
the JFCCF accounted for 65.2% of cases in Campo Grande and 
39.9% of cases in the entire state, which might have biased the 
results if cases were pooled together into fewer groups.
Laboratory testing routine
Sputum samples from suspected cases of PTB were tested 
for AAFB at local municipal laboratories and subsequently 
cultured in Bactec Mycobacterial Growth Indicator Tube 960 
(MGIT 960; Becton-Dickinson, Sparks, MD, USA) or 
Löwenstein–Jensen solid medium15 at the LACEN-MS. 
However, samples from four counties (Amambai, Corumbá, 
Dourados, and Ponta Porã) were tested locally for AAFB, seeded 
in Ogawa–Kudoh medium, and sent to the LACEN-MS.
Since 2010, smear testing has been shared by the LACEN-
MS and the Campo Grande Municipal Laboratory with a 
consequent increase in the number of cultures and DST.
Positive cultures were subsequently tested at the LACEN-
MS for susceptibility to rifampicin, isoniazid, streptomycin, 
and ethambutol using the proportion method16.
Resistance patterns detected on DST were validated at the 
Tuberculosis and Mycobacterial Testing Center of the Instituto 
Adolfo Lutz (São Paulo) or the Hélio Fraga Reference Center 
of the Fundação Oswaldo Cruz (Rio de Janeiro).
Five operational indicators (AAFB testing, M. tuberculosis 
culturing, positive M. tuberculosis cultures, DST on positive 
cultures, and DST on notified cases) and two epidemiological 
indicators which included the resistance rate ratio between new 
(primary resistance) and treated (acquired resistance) cases 
and multidrug resistance (MDR; resistance to both rifampicin 
and isoniazid) rate ratio between new and treated cases17, were 
examined for two periods: 2007-2010 and 2011-2014 which 
represent the period before and the period after suspected cases 
in Group 1 began to be tested at the LACEN-MS, respectively.
Statistical analysis
We used the chi-square test to evaluate associations between 
correctional facilities and other variables with Bonferroni 
correction for pairwise comparison of proportions when 
p values were significant in the overall analysis. Student’s 
t-test compared quantitative variables between periods. The 
chi-square test detected associations between facilities and 
rates of drug sensitivity/resistance, AAFB testing, cultures 
performed, DST performed, and susceptibility profiles, with 
Bonferroni correction for pairwise comparison of proportions 
when associations proved significant. Cross-period comparisons 
for mean rates of sensitive and resistant cases per group were 
performed using Student’s t-test. Data of other variables were 
subjected to descriptive statistical analysis. The SigmaPlot Exact 
Graphs and Data Analysis software, version 12.5, was used for 
statistical analysis with a significance level of 5%18.
RESULTS
In the 35 prisons investigated, PTB cases increased from 
358 in 2007-2010 to 654 in 2011-2014 (an 82.7% increase), 
representing prevalence rates (per 100,000 inmates) of 480 
and 972.9, respectively. Most of these 1012 cases (885) were 
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TABLE 1: Laboratory indicators for pulmonary tuberculosis and drug resistance diagnosis with respect to correctional facility and study period.
Variable















p value n % n % n % n % n % n %
AAFB testing
yes 70 71.4 301 98.4 <0.001 88 79.3 90 85.7 0.288 138 92.6 211 86.8 0.107
no 28 28.6 5 1.6 23 20.7 15 14.3 11 7.4 32 13.2
culturing
yes 59 60.2 301 98.4 <0.001 57 51.4 53 50.5 0.994 81 54.4 181 74.5 <0.001
no 39 39.8 5 1.6 54 48.6 52 49.5 68 45.6 62 25.5
positive cultures
yes 57 96.6 296 98.3 0.716 54 94.7 46 86.8 0.264 72 88.9 155 85.6 0.604
no 2 3.4 5 1.7 3 5.3 7 13.2 9 11.1 26 14.4
DST on positive 
cultures
yes 47 82.5 180 60.8 0.003 36 66.7 25 54.3 0.292 48 66.7 105 67.7 0.993
no 10 17.5 116 39.2 18 33.3 21 45.7 24 33.3 50 32.3
DST on notified 
cases
yes 47 48.0 180 58.8 0.035 36 32.4 25 23.8 0.209 48 32.2 105 43.2 0.039
no 51 52.0 126 41.2  75 67.6 80 76.2  101 67.8 138 56.8  
Group 1: Jair Ferreira de Carvalho Correctional Facility, Campo Grande. Group 2: other prison facilities in Campo Grande. Group 3: prisons located 
elsewhere in the state. n: notified cases of pulmonary tuberculosis; AAFB: alcohol–acid-fast bacilli; DST: drug sensitivity testing. P values as per the chi-
square test.
concentrated in five counties: Campo Grande (620), Dourados 
(122), Corumbá (63), Amambai (42), and Ponta Porã (38).
Across periods, operational indicators evolved as follows 
in Group 1: AAFB testing, 71.4 to 98.4% (p < 0.001); cultures 
performed, 60.2 to 98.4% (p < 0.001); positive cultures, 96.6 to 
98.3% (p = 0.716); DST for positive cultures, 82.5 to 60.8% (p = 
0.003); and DST coverage, 48.0 to 58.8% (p = 0.035). In Group 
2, none of these five indicators showed any increase. In Group 3, 
increases were observed in cultures performed (54.4 to 74.5%, 
p < 0.001) and DST coverage (32.2 to 43.2%, p = 0.039). No 
changes in positive culture rates were detected, whether within 
groups or statewide (Table 1 and Table 2).
Across groups, no significant differences were found in 
DST performance on positive cultures (~60%; p = 0.523) or in 
the resistance profiles of tested cultures (~70% sensitive, ~20% 
resistant; p = 0.700) (Table 3). 
Across periods, the rates of sensitive cases fell in all three 
groups, while those of resistant cases increased. The same 
patterns were seen in statewide rates (Table 4). 
Overall, resistance rates of 21.1% (76/361) and 30% (24/80) 
were observed among new and treated cases, respectively, with 
a 22.7% mean rate for all cases (100/441). Among uncombined 
drugs, primary resistance was highest for streptomycin 
(11.9%; 43/361) and was also observed in nine cases of MDR 
(2.5%; 9/361). Among treated cases, resistance was highest 
for streptomycin (15%; 12/80) and ethambutol (11.3%; 9/80). 
Primary and acquired MDR rates were 0.3% (1/361) and 1.3% 
(1/80), respectively (Table 5).
DISCUSSION
Increasing from 480.0 in 2007 to 972.9 in 2014, the PTB 
prevalence rates per 100,000 inmates in Mato Grosso do Sul 
were similar to the national rates reported for prisons19. A study 
comprising 59% of inmates in 12 prisons in the state throughout 
2013 revealed prevalence and incidence rates per 100,000 
prisoners of 951 and 1839, respectively14, with the latter being 
similar to the 830.6 rate found in a sample of 2237 prisoners 
in São Paulo in 200820. Our findings, however, reflect cases 
reported from a range of correctional facilities (closed, semi-
open, and open conditions, but not police precincts).
In 2014, Mato Grosso do Sul had the highest incarceration 
rate (568.9 per 100,000 population) and the fourth highest prison 
occupancy rate (216%), ranking 11th among the 28 Brazilian 
state-level administrative divisions in number of prisoners19. 
Overcrowding, compounded by poorly ventilated cells deprived 
of sunlight, potentiates the likelihood of bacillus transmission6,7,9.
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TABLE 3: Performance of DST of Mycobacterium tuberculosis cultures with respect to correctional facility in Mato Grosso do Sul, 2007-2014.
Testing
Group 1 Group 2
 
Group 3 p value
(chi-square test)
DST of positive cultures
yes 64.7 (227)* 61.0 (61)* 67.4 (153)*
0.523
no 35.3 (124)* 39.0 (39)* 32.6 (74)*
Drug sensitivity profile
sensitive 78.9 (179)* 77.0 (47)* 75.2 (115)*
0.700
resistant 21.1 (48)* 23.0 (14)* 24.8 (38)*
*Data expressed as relative frequencies (followed by absolute frequencies). Values in the same row followed by various letters differ significantly (chi-square 
test, p < 0.05, Bonferroni correction).







p value n % n %
AAFB testing
yes 296 82.7 602 92.0 <0.001
no 62 17.3 52 8.0
Culturing
yes 197 55.0 535 81.8 <0.001
no 161 45.0 119 18.2
Positive cultures
yes 183 92.9 497 92.9 0.873
no 14 7.1 38 7.1
DST of positive cultures
yes 131 71.6 310 62.4 0.032
no 52 28.4 187 37.6
DST of notified cases
yes 131 36.6 310 47.4 0.001
no 227 63.4 344 52.6  
n: notified cases of pulmonary tuberculosis; AAFB: alcohol–acid-fast bacilli; DST: drug sensitivity testing. p-values as per the chi-square test.
In 2014, Mato Grosso do Sul had the highest incarceration 
rate in the country (568.9 per 100,000 residents) and the fourth-
highest occupancy rate (216%), ranking 11th among the 28 
Brazilian state-level administrative units in terms of number of 
inmates19. In Mato Grosso do Sul, correctional facilities have 
operated at up to 500% capacity with cells holding between 35 
and 40 detainees who have an average of 2.1m2 of space per 
prisoner (less than half the minimum recommended standard), 
representing a pressing problem both in terms of human rights 
and public health9.
With a mean 82.7% increase between the first and the last year 
of study, the increase in the number of cases varied considerably 
across groups, from 212.2% cases in Group 1 (closed conditions) 
to 63.1% cases in Group 3 (three incarceration conditions) to 
Cunha EAT et al. - Pulmonary tuberculosis in Brazilian inmates
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TABLE 5: Resistance profiles in Mato Grosso do Sul, 2007-2014.
Resistance profile
New cases (361) Treated cases (80) Total cases (441)
Means*
n % n % n %
Resistant samples 76 21.1 24 30.0 100 22.7 21.76 ± 2.95
Monoresistance
S 43 11.9 12 15.0 55 12.5 11.40 ± 2.45
I 17 4.7 7 8.8 24 5.4 5.05 ± 0.57
R 3 0.8 2 2.5 5 1.1 1.55 ± 0.78
E 2 0.6 9 11.3 11 2.5 0.34 ± 0.23
Multidrug resistance
R + I 1 0.3 1 1.3 2 0.5 0.74 ± 0.55
Polyresistance
S + I 7 1.9 1 1.3 8 1.8 1.80 ± 0.51
S + R 1 0.3 0 0.0 1 0.2 0.20 ± 0.20
I + E 1 0.3 0 0.0 1 0.2 0.20 ± 0.20
S + R + E 1 0.3 0 0.0 1 0.2 0.35 ± 0.35
S + I + E 0 0.0 1 1.3 1 0.2 0.15 ± 0.15
S: streptomycin; I: isoniazid; R: rifampicin; E: ethambutol. *Means ± standard error of means.
TABLE 4: Mean percentages of sensitive and resistant cases with respect to study period and correctional facility in Mato Grosso do Sul, 2007-2014.
Testing Group 1 Group 2 Group 3 Mato Grosso do Sul
Cases tested for drug sensitivity 227 (51.5%) 61 (13.8%) 153 (34.7%) 441 (100.0)
Sensitive samples (%)
2007-2010 84.08 ± 5.87 90.0 ± 10.0 77.64 ± 7.76 82.10 ± 5.54
2010-2014 77.14 ± 4.72 70.54 ± 11.14 73.21 ± 3.64 75.75 ± 4.26
p value 0.393 0.241 0.623 0.398
Resistant samples (%)
2007-2010 15.93 ± 5.87 10.00 ± 10.0 22.36 ± 7.76 17.90 ± 5.54
2010-2014 22.86 ± 4.72 29.46 ± 11.14 26.80 ± 3.64 24.25 ± 4.26
p value 0.393 0.241 0.623 0.398
Data expressed as means ± standard error of means. p values as per Student’s t-test.
no variation in cases in Group 2 (also three conditions). The 
overall increase may have resulted from the 59.9% growth 
in the prison population (9,322 in 2007 to 14,904 in 2014) 
reported for the state19,21. Furthermore, specificities in this 
population may have also contributed. Although PTB incidence 
and mortality rates in Mato Grosso do Sul are similar to the 
national averages, the risks of morbidity and death from the 
disease are higher among indigenous individuals and residents 
of international border regions22. Moreover, the state’s location 
on a cross-national land route of drug and arms trafficking may 
be a potential contributing factor to increased local detention 
rates with a greater likelihood of detainees originating from 
neighboring countries (e.g., Peru and Bolivia) where endemic 
multidrug-resistant tuberculosis rates are high23. In 2010, 243 
out of 9688 inmates in Mato Grosso do Sul were foreigners 
(mostly Bolivians, Paraguayans and Peruvians)24.
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Difficulties searching for respiratory symptomatic inmates 
in the entire state during the study period limited this task to 
two prisons in Campo Grande that jointly held 2300 inmates. In 
2010-2014, the LACEN-MS performed 3621 AAFB testing and 
cultures (an average 724 exams per year) on samples originating 
from the prisons investigated which represented a coverage rate 
of 31.4%. However, this rate was lower than the 38.7% rate 
found for inmates in Carapicuíba, São Paulo State11. 
In the present study, culturing confirmed 523 PTB cases 
or 39% of early diagnosis, which was within the 30-40% 
range advocated by the World Health Organization (WHO) 
(where culturing is available15) and was similar to the 32.3% of 
early diagnosis found in southern Brazil25. Early treatment of 
paucibacillary forms interrupts the transmission chain, which is 
a desirable outcome in prison settings as paucibacillary forms 
facilitate propagation both of sensitive and resistant strains26. 
The rate of culture-confirmed cases in the present sample 
(>90%) proved similar to that found for inmates in Espírito 
Santo State in 2003-200627.
In Mato Grosso do Sul, the availability of culturing and 
DST for populations at a higher risk of drug resistance15 and 
the recommendation of both procedures for all tuberculosis 
cases detected among inmates28 predated national guidelines. In 
mid-2010, the LACEN-MS was imposed the extra burden of 
performing AAFB testing, cultures, and DST for the Jair Ferreira 
de Carvalho Correctional Facility (Group 1), which was previously 
done by the Campo Grande municipal laboratory, but the change 
does not appear to have biased our analysis since this prison 
accounted for 40% of cases reported for the state. No significant 
differences in DST-related aspects were observed among groups.
The measures implemented also addressed informing the 
medical and nursing teams of the JFCCF on the importance 
of promoting a continuous, systematic search for inmates 
presenting with cough for the purpose of sputum collection. 
Measures implemented also addressed improvements to the 
operational routine of sample transit and processing, prompt 
communication of positive results via telephone call, and 
providing JFCCF technicians access to the LACEN-MS 
Information System for obtaining examination results.
Among new cases, resistance rates–streptomycin, 14.4%; 
isoniazid, 6.9%; rifampicin, 1.4%; ethambutol, 1.1% (whether 
uncombined or in association, for each drug)–were roughly 
twice those observed for the state’s general population, probably 
reflecting recent intra-institutional transmission29, a trait not 
devoid of consequences for the general population13. Molecular 
biology studies have revealed clustering in over 68%29 and 
87%30 of strains. Among the state’s general population, primary 
monoresistance (including the four drugs considered here) has 
been associated with border regions and comorbidity (diabetes 
and alcoholism)31, features that may apply to the prison 
population of Mato Grosso do Sul. However, MDR rates of 
0.3% among new cases and 1.3% among treated cases were 
both lower than among the state’s general population (0.6% 
and 6.3%, respectively)31.
In the present study, the overall resistance rate exceeded 
those found for inmates in other Brazilian states25,29-33, except 
for MDR, which proved four times lower in our sample. The 
stability of resistance rates from the first to the second period 
may be indicative of effectiveness in control measures15,28. The 
high positivity rate of resistant-strain smears (66.0%) was lower 
than that reported for prisoners in São Paulo32.
In Dourados county of Mato Grosso do Sul, 54% of 
M. tuberculosis strains detected in the general population had 
the same profile as that found in inmates12 drawing attention to 
the risk of spread across populations.
The high prevalence of PTB among prisoners in Mato Grosso 
do Sul may reflect not only poor ventilation and overcrowding 
conditions, but also reflect the overall growth of the population 
and the effects of ongoing measures toward the active search 
of suspected cases. Ongoing investments in the provisions of 
culturing, DST, and technical training, efforts combining state 
and municipal human resources, facilitated access to service 
indicators, and raised awareness among prison managing 
boards on the urgency of controlling communicable diseases 
may have helped shape the results found in this investigation. 
Nevertheless, the findings highlight the need for health policies 
that prioritize laboratory diagnosis of suspected cases and 
monitoring of sensitive and resistant treatments (measures 
unfeasible without sufficiently trained technical staff to 
follow every diagnosed case) in order to interrupt the chain of 
transmission and attenuate the endemic character of the disease.
Recent studies have stressed the need for early diagnosis 
based on new technologies, as well as the importance of 
architectural interventions in improving natural ventilation and 
reducing overcrowding in correctional facilities. Additional 
studies might identify aggravating factors such as unmet 
healthcare demand for suspected cases, delayed treatment, 
outcomes of treated cases, and operational and logistical issues 
affecting care provision.
While acknowledging the limitations of studies based solely 
on secondary data, which tend to preclude the investigation 
of features such as behaviors, attitudes, and clinical histories, 
we believe the data used in the present study are sufficient for 
evaluating the effectiveness of an intervention implemented in the 
diagnosis of tuberculosis among inmates in Mato Grosso do Sul.
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